AKBA
$3.36
Akebia Therapeutics
$.14
4.35%
AKBA
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  ($0.38)
Revenue:  $101.21 Mil
Tuesday
Feb 11
7:55 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AKBA reports earnings?
Beat
Meet
Miss

Where is AKBA's stock price going from here?
Up
Flat
Down
Stock chart of AKBA
Analysts
Summary of analysts' recommendations for AKBA
Score
Grade
Pivots
Resistance
$3.64
$3.53
$3.45

$3.34

Support
$3.25
$3.14
$3.06
Tweet
Growth
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsCelgeneInterCeptJohnson & JohnsonMylanZoetisEndo International plcUltragenyx Pharmaceutical